Navigation Links
FDA Approves New Flu Vaccine
Date:9/28/2007

That should ensure adequate supply for coming influenza season, officials say

FRIDAY, Sept. 28 (HealthDay News) -- With flu season fast approaching, U.S. health officials announced Friday the approval of a new vaccine intended for people 18 and older.

The vaccine, called Afluria, is designed to protect adults from influenza viruses type A and type B.

"Today's action is important, because it brings to six the number of companies licensed to supply flu vaccine in the United States," Dr. Jesse L. Goodman, director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, said during an afternoon teleconference.

Goodman noted that in 2000, there were only three manufacturers of flu vaccine for the United States. In 2004, one manufacturer had problems with the sterility of its British production facility, which caused a severe shortage of vaccine in the United States.

Since then, the FDA has been looking for other vaccine manufacturers to fill the gap and ensure that even if there were a problem with one manufacturer, there would still be an adequate supply, Goodman said.

Afluria was approved using the FDA's accelerated approval process, said Norman Baylor, director of FDA's office of vaccines research and review.

"This process allows the agency to approve products for serious or life-threatening diseases based on early evidence of the product's effectiveness," Baylor said at the teleconference. "This accelerated approval process can reduce the time for needed medical product to become available to the public."

Afluria is made by CSL Limited of Parkville, Australia. The company is expected to supply about 2 million doses of the vaccine to the United States market this year.

The approval means there will be an estimated 132 million doses of flu vaccine for the 2007-2008 influenza season. That's 10 million doses more than last year, officials said.

The Afluria vaccine is made with inactivated influenza viruses grown in chicken eggs. Those allergic to eggs or any other component of the vaccine should not receive the vaccine, officials said.

The most common side effects are tenderness, pain, redness and swelling at the injection site, and headache, fatigue and muscle aches.

Flu season in the United States can start in October and last until May. More than 200,000 people are hospitalized with influenza each year in the country, and about 36,000 people die annually from complications from the disease, according to the U.S. Centers for Disease Control and Prevention.

The CDC recommends that people should get their flu shot starting in September, but it's worthwhile to get a shot as late as January.

The CDC says anyone looking to avoid the flu should get vaccinated. But those at high risk for complications from the flu should get a shot. Those people include: children aged 6 months to 5 years old; pregnant women; people 50 years of age and older; people of any age with certain chronic medical conditions; and people who live in nursing homes and other long-term care facilities.

Also urged to get vaccinated are people who live with or care for those at high risk for complications from flu, including health-care workers.

More information

To learn more about the flu, visit the CDC.



SOURCES: Sept. 28, 2007, teleconference with Jesse L. Goodman, M.D., M.P.H., director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Md.; Norman Baylor, Ph.D., director, office of vaccines research and review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. FDA Approves Contraceptive Ring
3. FDA approves new device to treat womens bleeding disorder
4. FDA Approves New HIV Drug, Viread
5. FDA Approves Birth Control Skin Patch
6. FDA approves surgical gel
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA approves drug for rare liver disease
10. FDA approves first pocket-sized EKG machine
11. FDA Approves New Anti-Clotting Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology: